2. GPCR/G Protein Epigenetics Cell Cycle/DNA Damage
  3. G Protein-coupled Receptor Kinase (GRK) HDAC
  4. GRK2 modulator 1

GRK2 modulator 1 is an orally active, brain-penetrant and selective GRK2 modulator. GRK2 modulator 1 enhances the active, non-phosphorylated GRK2 and prevents mitochondrial GRK2 and TOMM6 aggregation. GRK2 modulator 1 enhances the non-amyloidogenic processing of APP and prevent PHF-tau, neurodegeneration, and neuronal loss. GRK2 modulator 1 decreases the senescence marker, UPAR, reduces the Alzheimer disease (AD)-related mortality, and prolongs survival. GRK2 modulator 1 exerts neuroprotection by inhibiting HDAC6, and counteracts age-related cardiac dysfunction. GRK2 modulator 1 can be used for research on AD.

For research use only. We do not sell to patients.

GRK2 modulator 1

GRK2 modulator 1 Chemical Structure

CAS No. : 2234900-83-3

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

GRK2 modulator 1 Related Antibodies

Top Publications Citing Use of Products

View All HDAC Isoform Specific Products:

View All Isoforms
HDAC HDAC1 HDAC2 HDAC3 HDAC4 HDAC5 HDAC6 HDAC7 HDAC8 HDAC9 HDAC10 HDAC11 HD1 HD2

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

GRK2 modulator 1 is an orally active, brain-penetrant and selective GRK2 modulator. GRK2 modulator 1 enhances the active, non-phosphorylated GRK2 and prevents mitochondrial GRK2 and TOMM6 aggregation. GRK2 modulator 1 enhances the non-amyloidogenic processing of APP and prevent PHF-tau, neurodegeneration, and neuronal loss. GRK2 modulator 1 decreases the senescence marker, UPAR, reduces the Alzheimer disease (AD)-related mortality, and prolongs survival. GRK2 modulator 1 exerts neuroprotection by inhibiting HDAC6, and counteracts age-related cardiac dysfunction. GRK2 modulator 1 can be used for research on AD[1].

IC50 & Target

HDAC6

 

GRK2

 

In Vitro

GRK2 modulator 1 (CPD10) interacts with non-phosphorylated GRK2 and phospho-S670-GRK2 in brain lysates from AD mice[1].
GRK2 modulator 1 enhances the active, non-phosphorylated GRK2 and prevents mitochondrial GRK2 and TOMM6 aggregation in a cellular AD model of primary cortical neurons[1].
GRK2 modulator 1 prevents the Aβ1-42-induced mitochondrial dysfunction, as measured by ACO2 activity, with an EC50 value of 155.6 nM[1].
GRK2 modulator 1 inhibits the phospho-S670-GRK2 with an IC50 value of 2.2 μM, whereas only a high concentration of >100 μM affects the kinase activity of wild-type GRK2[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

GRK2 modulator 1 Related Antibodies
In Vivo

GRK2 modulator 1 (CPD10) (2.7-24 mg/kg/d; p.o.; daily for 6 months) counteracts major neurodegenerative AD symptoms, promotes neurogenesis, slows senescence, and enhances survival in Tg2576 AD mice[1].
GRK2 modulator 1 (8 mg/kg/d; p.o.; daily for 8 weeks) retards neurodegenerative PHF-tau hyperphosphorylation and neuronal loss in male Tg2576 mice by chronic unpredictable mild stress (CUMS)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Tg2576 mice (12 months old) were used for an AD model[1].
Dosage: 2.7 mg/kg/d; 8 mg/kg/d; 24 mg/kg/d
Administration: p.o.; daily for 6 months
Result: Largely prevented dysfunctional GRK2 and TOMM6 aggregated on hippocampal mitochondria and improved the mitochondrial function with higher mitochondrial ACO2 activities and ATP levels than untreated, 18- and 12-month-old Tg2576 mice.
Significantly up-regulated transcripts related to nervous system development.
Induced neurogenesis, which was documented by the increased neuronal marker, NeuN.
Reduced the inflammatory gliosis response, as reflected by the reduced astrocyte marker, Gfap.
Increased the AD protective and Aβ-clearing microglia marker, Cx3cr1.
Shifted the APP-processing activities toward the non-amyloidogenic route.
Strongly reduced hippocampal Aβ plaques, insol­uble and soluble Aβ, and mitochondrial Aβ in a dose-dependent manner.
Protected from the increased Aβ-related mortality.
Significantly reduced hippocampal contents of the senes­cence marker, UPAR.
Animal Model: Tg2576 mice (male; 14 months old) were received 2 months of chronic unpredictable mild stress to mimic environmental stress[1].
Dosage: 8 mg/kg/d
Administration: p.o.; daily for 8 weeks
Result: Prevented the CUMS-enhanced PHF-tau.
Maintained inhibitory phosphorylation of the tau kinase, GSK3B, at serine-9.
Retarded the CUMS-induced neuronal loss and improved the spatial memory of CUMS-subjected Tg2576 mice in the Morris water maze test.
Reduced the CUMS-induced mitochondrial phospho-S670-GRK2 aggregates, which was triggered by increased PHF-tau.
Molecular Weight

363.36

Formula

C21H17NO5
CAS No.
SMILES

O=C1C(C(C2CC2)=O)=C(O)C(C3=CC=CC=C3)N1C4=CC=C(OCO5)C5=C4
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

GRK2 modulator 1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

GRK2 modulator 12234900-83-3G Protein-coupled Receptor Kinase (GRK)HDACHistone deacetylasesGRK2 modulatorTOMM6APPPHF-tauneurodegenerationneuronal lossUPARHDAC6neuroprotectionAlzheimer diseaseInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
GRK2 modulator 1
Cat. No.:
HY-183057
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.